Quinidine Gluconate

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 105 Experts worldwide ranked by ideXlab platform

Mark A. Travassos - One of the best experts on this subject based on the ideXlab platform.

Howard C. Dittrich - One of the best experts on this subject based on the ideXlab platform.

  • Prolonged Asymptomatic Torsade de Pointes
    Journal of Cardiovascular Electrophysiology, 2008
    Co-Authors: Gregory Schieman, A.robert Blacky, Pascal Nicod, Howard C. Dittrich
    Abstract:

    Torsade de pointer is often associated with syncope, particularly when prolonged. We report a cane of prolonged asymptomatic torsade de pointes in a 68-year-old woman being treated with Quinidine Gluconate for paroxysmal atrial fibrillation. Ambulatory monitoring obtained one week after an increase in the daily qninidine dosage demonstrated one minute of polymorphous ventricular tachycardia. The patient remained entirely asymptomatic throughout the time of the arrhythmia. Therefore, a lack of symptoms in patients at risk for torsade de pointes may not exclude the presence of this arrhythmia.

Paul M. Arguin - One of the best experts on this subject based on the ideXlab platform.

Rebecca A. Krey - One of the best experts on this subject based on the ideXlab platform.

Gregory Schieman - One of the best experts on this subject based on the ideXlab platform.

  • Prolonged Asymptomatic Torsade de Pointes
    Journal of Cardiovascular Electrophysiology, 2008
    Co-Authors: Gregory Schieman, A.robert Blacky, Pascal Nicod, Howard C. Dittrich
    Abstract:

    Torsade de pointer is often associated with syncope, particularly when prolonged. We report a cane of prolonged asymptomatic torsade de pointes in a 68-year-old woman being treated with Quinidine Gluconate for paroxysmal atrial fibrillation. Ambulatory monitoring obtained one week after an increase in the daily qninidine dosage demonstrated one minute of polymorphous ventricular tachycardia. The patient remained entirely asymptomatic throughout the time of the arrhythmia. Therefore, a lack of symptoms in patients at risk for torsade de pointes may not exclude the presence of this arrhythmia.